Deep-Dive Due Diligence AI Generated Report on DSS, Inc. (DSS)

Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.

These reports are generated using OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.

Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.


DSS_OUT_1 [2025-03-21 08:11:36 -0400] 1876 Bytes | 539 tokens | Cum: 539 tkns (6.74% of 8k)
==========================================================================

Listen up, partner—it's 8:11:35 AM on Fri Mar 21, 2025 -0400, and I’m revved up about DSS (DSS), climbing from 0.924 to 1.12. This stock is buzzing big-time—do we have a hidden gem, or a flash in the pan? Help me sift through the data!

Here's the first list of news for DSS:

C1 - Feb-26-25 08:30AM - DSS, Inc. Announces Sale of Celios to Impact BioMedical, Streamlining Portfolio for Strategic Growth
C2 - Feb-03-25 08:50AM - DSS, Inc. Issues Letter to Shareholders
C3 - Sep-16-24 04:26PM - DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value
C4 - Sep-10-24 09:00AM - AmericaFirst Funds Trust Announces Changes to Board of Trustees
C5 - Aug-26-24 04:08PM - DSS, Inc. Names Jason Grady as Interim Chief Executive Officer
C6 - Jan-30-24 08:05AM - Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose Technology Entitled "Low Glycemic Sugar Composition."
C7 - Jan-04-24 08:15AM - DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market
C8 - Dec-22-23 04:30PM - DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on DSS (DSS)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

DSS_IN_2 [2025-03-21 08:11:37 -0400] 2 Bytes | 2 tokens | Cum: 541 tkns (6.76% of 8k)
==========================================================================

C1

DSS_OUT_3 [2025-03-21 08:11:40 -0400] 1042 Bytes | 299 tokens | Cum: 840 tkns (10.50% of 8k)
==========================================================================

Showing C1 (chunk 1 of 3): C1:
**DSS, Inc. Announces Sale of Celios to Impact BioMedical, Streamlining Portfolio for Strategic Growth**
Date: Feb-26-25 08:30AM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/02/26/3032921/0/en/DSS-Inc-Announces-Sale-of-Celios-to-Impact-BioMedical-Streamlining-Portfolio-for-Strategic-Growth.html

February 26, 2025 08:30 ET| Source:DSS, Inc.DSS, Inc.

ROCHESTER, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company focused on innovation-driven business models, today announced the sale of its Celios® air purification asset to Impact BioMedical Inc. (NYSE American: IBO) in a strategic, all-equity transaction valued at approximately $1.15 million. This divestiture aligns with DSS’ ongoing strategy to optimize its portfolio and concentrate on core growth areas.

Celios® is a cutting-edge air purification technology

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

DSS_IN_4 [2025-03-21 08:11:40 -0400] 3 Bytes | 2 tokens | Cum: 842 tkns (10.53% of 8k)
==========================================================================

MOR

DSS_OUT_5 [2025-03-21 08:11:42 -0400] 1054 Bytes | 213 tokens | Cum: 1055 tkns (13.19% of 8k)
==========================================================================

Showing C1 (chunk 2 of 3): featuring a patented three-stage filtration system capable of removing ultrafine particles as small as ten (10) nanometers, helping to improve indoor air quality and mitigate airborne health risks. The sale of this asset allows DSS to focus on other high-impact investments across its diversified business segments.

“The sale of Celios® to Impact BioMedical represents another step in our strategic efforts to streamline our holdings and focus on our core business objectives,” said Jason Grady, CEO of DSS, Inc. “Impact BioMedical is well-positioned to leverage Celios’® innovative air purification technology, and we believe this transition will maximize the platform’s potential while allowing DSS to continue to focus into areas with stronger long-term synergies.”

This transaction strengthens DSS’ commitment to advancing its strategic vision by concentrating on key business verticals that d

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

DSS_IN_6 [2025-03-21 08:11:42 -0400] 3 Bytes | 2 tokens | Cum: 1057 tkns (13.21% of 8k)
==========================================================================

NEX

DSS_OUT_7 [2025-03-21 08:11:43 -0400] 942 Bytes | 284 tokens | Cum: 1341 tkns (16.76% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-21T12:00:10Z - Meet the experts joining our "How to Successfully Launch & Scale in Malta" panel at the EU-Startups ...
A2 - 2025-03-21T11:46:34Z - Customs confiscate smuggled goods worth N84.2m in Kebbi - The Street Journal...
A3 - 2025-03-21T11:14:49Z - JUST-IN: Nnamdi Kanu Apologises Over Misconduct In Court, Pleads Not Guilty In Fresh Charges...
A4 - 2025-03-21T10:57:22Z - I'm Not Guilty Of Terrorism Accusation, Nnamdi Kanu Tells Court...
A5 - 2025-03-21T10:57:17Z - Biafra: Again, Nnamdi Kanu denies terrorism accusations by Nigerian govt...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

DSS_IN_8 [2025-03-21 08:11:43 -0400] 2 Bytes | 2 tokens | Cum: 1343 tkns (16.79% of 8k)
==========================================================================

A1

DSS_OUT_9 [2025-03-21 08:11:45 -0400] 1038 Bytes | 264 tokens | Cum: 1607 tkns (20.09% of 8k)
==========================================================================

Showing A1 (chunk 1 of 8): A1:
**Meet the experts joining our "How to Successfully Launch & Scale in Malta" panel at the EU-Startups Summit 2025! | EU-Startups**Date: 2025-03-21Source: {'uri': 'eu-startups.com', 'dataType': 'news', 'title': 'EU-Startups'}URL: https://www.eu-startups.com/2025/03/meet-the-experts-joining-our-how-to-successfully-launch-scale-in-malta-panel-at-the-eu-startups-summit-2025/On April 24-25, 2025, the EU-Startups Summit returns to Malta, bringing together many of Europe's most promising founders, startup enthusiasts, and investors for two days of networking, inspiration and learning.

Malta is emerging as a prime hub for startups and scale-ups looking to establish and expand in Europe. But what does it take to launch and scale successfully in the country? From funding opportunities and strategic partnerships to navigating regulatory landscapes, our panel "How to Successfully Launch & Scale

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

DSS_IN_10 [2025-03-21 08:11:45 -0400] 3 Bytes | 2 tokens | Cum: 1609 tkns (20.11% of 8k)
==========================================================================

NEX

DSS_OUT_11 [2025-03-21 08:11:47 -0400] 1134 Bytes | 340 tokens | Cum: 1949 tkns (24.36% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-01-30T13:05:00Z - Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
B2 - 2024-01-04T13:15:00Z - DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market
B3 - 2023-12-28T18:07:18Z - Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
B4 - 2023-12-22T21:30:00Z - DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan
B5 - 2023-11-28T13:10:00Z - Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
B6 - 2023-11-08T13:31:00Z - DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

DSS_IN_12 [2025-03-21 08:11:47 -0400] 2 Bytes | 2 tokens | Cum: 1951 tkns (24.39% of 8k)
==========================================================================

B2

DSS_OUT_13 [2025-03-21 08:11:50 -0400] 596 Bytes | 177 tokens | Cum: 2128 tkns (26.60% of 8k)
==========================================================================

Showing B2 (chunk 1 of 1): B2:
**DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2024/01/04/2803989/0/en/DSS-Inc-Chairman-Chan-Acquires-672-173-shares-of-DSS-In-Open-Market.htmlChairman of the Board Heng Fai Ambrose Chan Adds 672,173 Shares to Increase Investment in Company Chairman of the Board Heng Fai Ambrose Chan Adds 672,173 Shares to Increase Investment in Company

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

DSS_IN_14 [2025-03-21 08:11:50 -0400] 235 Bytes | 51 tokens | Cum: 2179 tkns (27.24% of 8k)
==========================================================================

This news article reports that Heng Fai Ambrose Chan, the Chairman of DSS, Inc., has purchased an additional 672,173 shares of the company in the open market. This move signifies a significant increase in his investment in the company.

DSS_OUT_15 [2025-03-21 08:11:52 -0400] 1129 Bytes | 314 tokens | Cum: 2493 tkns (31.16% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S2 - 2025-02-06 8-K Item 1.01 Entry into a Material Definitive Agrmt.

On February 6, 2025, as a bonus for compensation awarded to Heng Fai Holdings Limited (HFHL), a Hong Kong Company, which is beneficially owned by Mr. Heng Fai Ambrose Chan, Director of DSS, Inc., and pursuant to DSS, Incs. (...

S3 - 2024-12-30 8-K Item 1.01 Entry into a Material Definitive Agrmt.

On December 27, 2024, True Partner International Limited (True Partner or the Subscriber), a wholly owned subsidiary of DSS Fin Management, Inc. entered into a share subscription agreement (the Share Subscription Agree...

S4 - 2024-12-16 8-K Item 1.01 Entry into a Material Definitive Agrmt.

On December 10, 2024, DSS, Inc. (the Company or the Seller) entered into securities purchase agreement(s) (the Purchase Agrmt(s) ) with Alset Inc. (Alset or the Buyer) pursuant to which the Company agreed to sell and iss...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

DSS_IN_16 [2025-03-21 08:11:52 -0400] 2 Bytes | 2 tokens | Cum: 2495 tkns (31.19% of 8k)
==========================================================================

S2

DSS_OUT_17 [2025-03-21 08:11:57 -0400] 713 Bytes | 199 tokens | Cum: 2694 tkns (33.67% of 8k)
==========================================================================

Showing S2 (chunk 1 of 1): S2:
Item 1.01 Entry into a Material Definitive Agreement.

On February 6, 2025, as a bonus for compensation awarded to Heng Fai Holdings Limited (HFHL), a Hong Kong Company, which is beneficially owned by Mr. Heng Fai Ambrose Chan, Director of DSS, Inc., and pursuant to DSS, Incs. (the Company) 2020 Employee, Director and Consultant Equity Incentive Plan (the Plan), HFHL was awarded one million (1,000,000) shares of the Companys common stock under the Plan, for services rendered. The issuance was approved by the board of directors (the Board) on January 31, 2025....

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

DSS_IN_18 [2025-03-21 08:11:57 -0400] 298 Bytes | 87 tokens | Cum: 2781 tkns (34.76% of 8k)
==========================================================================

On February 6, 2025, Heng Fai Holdings Limited (HFHL), a company owned by Mr. Heng Fai Ambrose Chan, received a bonus of one million shares of DSS, Inc.'s common stock. This was part of DSS, Inc.'s 2020 Equity Incentive Plan and was approved by the company's board of directors on January 31, 2025.

DSS_OUT_19 [2025-03-21 08:12:12 -0400] 4408 Bytes | 1279 tokens | Cum: 4060 tkns (50.75% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+--------------------+---------------------+-----------------------+------------------------+------------------------+-------------------------+
| Volume: 706,243 | SMA50: 3.99% | Market Cap: 6.53M | Option/Short: No / Yes | Sales past 5Y: 32.01% | Sales Surprise: -26.98% |
+--------------------+---------------------+-----------------------+------------------------+------------------------+-------------------------+
| Avg Volume: 31.41K | SMA200: -23.73% | Shs Outstand: 7.07M | Short Float: 0.43% | Employees: 95 | EPS Surprise: -50.00% |
+--------------------+---------------------+-----------------------+------------------------+------------------------+-------------------------+
| Rel Volume: 16.51 | Perf Week: 9.74% | Shs Float: 1.85M | Short Ratio: 0.25 | Debt/Eq: 1.24 | P/E: - |
+--------------------+---------------------+-----------------------+------------------------+------------------------+-------------------------+
| RSI (14): 56.40 | Perf Month: -0.66% | Inst Own: 1.72% | Short Interest: 0.01M | Sales Y/Y TTM: -40.40% | Earnings: - |
+--------------------+---------------------+-----------------------+------------------------+------------------------+-------------------------+
| ATR (14): 0.06 | Perf Quarter: 1.54% | Insider Own: 73.79% | Beta: 1.82 | ROE: -60.57% | |
+--------------------+---------------------+-----------------------+------------------------+------------------------+-------------------------+
| SMA20: 3.78% | Index: - | Insider Trans: 24.48% | Sales Q/Q: 33.88% | ROI: -67.17% | |
+--------------------+---------------------+-----------------------+------------------------+------------------------+-------------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

Inside Trans: DSS, INC. (DSS) by Chan Heng Fai Ambrose (Unknown Title) on 2025-02-06
- Common Stock: 1000000 shares at $0 (I)

[Company Financial Summary]
[Company Details]
Name: DSS, Inc.
Market Cap: N/A
Shares Outstanding: N/A
Sector: PAPERBOARD CONTAINERS & BOXES

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 25019000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -80206000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.924
Average Volume: 42417.82
30-Day High: 0.9416
30-Day Low: 0.842

[Detailed Financials: Q3 2024]
- Total Assets: $142,657,000.0
- Total Liabilities: $72,979,000.0
- Total Equity: $69,679,000.0
- Current Assets: $68,806,000.0
- Current Liabilities: $59,081,000.0

[Income Statement: Q3 2024]
- Revenue: $5,599,000.00
- Net Income: $-5,701,000.0
- Operating Income: $-4,671,000.0
- Earnings Per Share (EPS): -0.75

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $912,000

[Detailed Financials: Q2 2024]
- Total Assets: $144,448,000.0
- Total Liabilities: $71,298,000.0
- Total Equity: $73,150,000.0
- Current Assets: $67,698,000.0
- Current Liabilities: $57,666,000.0

[Income Statement: Q2 2024]
- Revenue: $4,211,000.00
- Net Income: $-4,954,000.0
- Operating Income: $-4,935,000.0
- Earnings Per Share (EPS): -0.66

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $1,467,000.0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

DSS_IN_20 [2025-03-21 08:12:12 -0400] 1292 Bytes | 286 tokens | Cum: 4346 tkns (54.33% of 8k)
==========================================================================

1) Brief Summary: DSS, Inc. presents a mixed financial picture. The company has shown impressive sales growth over the past 5 years (32.01%), but it has also experienced significant sales and EPS surprises (-26.98% and -50.00% respectively). The firm maintains a high insider ownership (73.79%), suggesting a strong belief in the company’s future. However, the company's substantial debt/equity ratio (1.24) and negative return on equity (-60.57%) could be points of concern. The company has a relatively low market capitalization of 6.53M, indicating that it is a small-cap company. The volume of trading is high compared to the average volume, suggesting increased investor interest.

2) MARKET_SCORE: Given the mixed financial signals and considering the recent performance, it's difficult to predict the market score confidently. However, considering the high insider ownership and sales growth, I would assign a MARKET_SCORE[60].

3) PRICE_TARGET: Given the current price of $0.924 and the recent volatility, I would anticipate some potential for growth. However, given the negative earnings and high debt/equity ratio, a conservative estimate would be a 10% increase. Thus, PRICE_TARGET[$1.016].

4) AI_RPT_HEADLINE: "DSS, Inc. Shows Promising Sales Growth Amid Financial Volatility."

DSS_OUT_21 [2025-03-21 08:12:17 -0400] 676 Bytes | 167 tokens | Cum: 4513 tkns (56.41% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

DSS_IN_22 [2025-03-21 08:12:17 -0400] 298 Bytes | 61 tokens | Cum: 4574 tkns (57.17% of 8k)
==========================================================================

As a financial analyst, I would choose X2 - More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes. These documents contain comprehensive information about a company's financial health and potential risks, which could significantly enhance the quality of my analysis.

DSS_IN_23 [2025-03-21 08:12:18 -0400] 126 Bytes | 29 tokens | Cum: 4603 tkns (57.54% of 8k)
==========================================================================

====================================
[2025-03-21 05:12:18] # Analysis Completed
Elapsed Time: 43.44 seconds




Scroll to Top